Uncategorized

Johnson & Johnson Reports 2009 First-Quarter Results

NEW BRUNSWICK, N.J., April 14, 2009 /PRNewswire-FirstCall via COMTEX News Network/ — Johnson & Johnson (NYSE: JNJ) today announced sales of $15.0 billion for the first quarter of 2009, a decrease of 7.2% as compared to the first quarter of 2008. Operational results declined 1.2% and the negative impact of currency was 6.0%. Domestic sales declined 5.0%, while international sales declined 9.6%, reflecting operational growth of 3.0% and a negative currency impact of 12.6%.

Net earnings for the first quarter of 2009 were $3.5 billion, representing a decrease of 2.5%, as compared to the same period in 2008. Diluted earnings per share for the first quarter of 2009 was $1.26, the same versus a year ago. The Company confirmed its earnings guidance for full-year 2009 of $4.45 – $4.55 per share, which excludes the impact of special items.

“Despite challenging economic and near term business pressures, we continue to deliver solid financial results,” said William C. Weldon, Chairman and Chief Executive Officer. “We are continuing to make strategic investments in order to bring important new products to market, positioning us well for long-term growth.”

Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button